GEN Exclusives

More »

GEN News Highlights

More »
May 7, 2013

TSRI, Janssen Team Up on Infectious Disease Research

  • The Scripps Research Institute (TSRI) and Janssen Pharmaceuticals are collaborating on infectious disease research, with an initial project focusing on influenza, the organizations today announced.

    Under the terms of this five-year agreement, Janssen is entitled to certain license rights, and will contribute research assistance through its Crucell Vaccine Institute. This collaboration builds on previous research on the influenza virus conducted jointly by TSRI and Janssen. Financial terms of the collaboration were not disclosed.

    "We're delighted to partner with Janssen in this work that could have a significant impact on human health," Michael Marletta, TSRI president and CEO, said in a statement. "The new agreement leverages the institute's significant strengths in structural biology to move forward new therapies and vaccines."


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?